Sinovac Biotech Ltd (NASDAQ:SVA)

7.94
Delayed Data
As of Jun 15
 0.00 / 0.00%
Today’s Change
5.41
Today|||52-Week Range
8.75
+0.76%
Year-to-Date
No recent news for Sinovac Biotech Ltd.

Today’s Trading

Previous close7.94
Today’s open7.79
Day’s range7.51 - 8.05
Volume224,807
Average volume (3 months)38,219
Market cap$446.8M
Data as of 4:00pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)-168.50%
Earnings growth (this year)--
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+7.44%
P/E ratio17.6
Price/Sales4.64
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.03-0.42%
AVEOAveo Pharmaceuticals...+0.01+0.45%
ACIUAC Immune SA-0.48-5.00%
GLYCGlycoMimetics Inc-0.35-2.21%
Data as of 9:38am ET, 06/18/2018

Financials

Last reporting dateApril 11, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$72.4M
Annual profit (last year)-$3.1M
Net profit margin-4.05%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
Secretary
Wei Dong Yin
Chief Financial Officer &
Vice President
Nan Wang
Corporate headquarters
Beijing, Beijing

Forecasts